Orphenadrine hydrochloride appears as odorless white or almost white crystalline powder. pH (aqueous solution) about 5.5. Bitter numbing taste. ORPHENADRINE HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated in parkinson disease. It is grouped under the following drug class(es): Anticholinergics. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mephenamin, Mebedrol and Disipal. Its PubChem CID is 9568.
Orphenadrine hydrochloride
| CAS No | 341-69-5 |
|---|---|
| Molecular Formula | C18H24ClNO |
| Molecular Weight | 305.8 g/mol |
| Synonyms | N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Orphenadrine hydrochloride appears as odorless white or almost white crystalline powder. 5. Bitter numbing taste. ORPHENADRINE HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated in parkinson disease.
The listed CAS number is 341-69-5.
The listed molecular formula is C18H24ClNO.
The listed molecular weight is 305.8 g/mol.
N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;hydrochloride.
The source lists Mephenamin, Mebedrol and Disipal.